Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
dOFM Bioequivalence Study for Lidocaine/Prilocaine
NCT04050826Phase 1Completed
- Sponsor
- JOANNEUM RESEARCH
- Start
- Sep 2019
- Primary completion
- Dec 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of lidocaine 10% oropharyngeal spray and prilocaine, sponsored by JOANNEUM RESEARCH. Primary endpoints: Area under the dermal concentration versus time curve for lidocaine at 13 hours, Area under the dermal concentration versus time curve for prilocaine at 13 hours and 2 more. Started Sep 2019; status: completed.
02
Drugs
lidocaine 10% oropharyngeal sprayprilocaine
Beyond the preview
Go deeper on NCT04050826.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04050826.